WX [WuXi PharmaTech (Cayman)] 6-K: WuXi PharmaTech (Cayman) Inc. Form 6-K TABLE OF
[WuXi PharmaTech (Cayman) Inc. Form 6-K TABLE OF CONTENTS Page 3 4 PRESS RELEASE DATED FEBRUARY 15, 2012]
TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)
[99 TPI Reports Second Quarter Fiscal Year 2012 Financial Results CHENGDU, China, Feb. 14, 2012 -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the second quarter of Fiscal Year 2012. Second quarter fiscal year 2012 ended] [Tianyin Pharmaceutical Inc. (TPI) F2Q12 Earnings Call February 14, 2012 8:30 AM ET Operator Good day ladies and gentlemen thank you for standing by. Welcome to the Tianyin Pharmaceutical Co., Inc., second quarter 2012 annual financial results conference call. During today’s presentation, all parties will be in a listen-only mode. Following the presentation, the conference will be opened for questions.] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT February 14, 2012 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]
TPI [TIANYIN PHARMACEUTICAL] 8-K: 99 TPI Reports Second Quarter Fiscal Year 2012
[99 TPI Reports Second Quarter Fiscal Year 2012 Financial Results CHENGDU, China, Feb. 14, 2012 -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the second quarter of Fiscal Year 2012. Second quarter fiscal year 2012 ended] [Tianyin Pharmaceutical Inc. (TPI) F2Q12 Earnings Call February 14, 2012 8:30 AM ET Operator Good day ladies and gentlemen thank you for standing by. Welcome to the Tianyin Pharmaceutical Co., Inc., second quarter 2012 annual financial results conference call. During today’s presentation, all parties will be in a listen-only mode. Following the presentation, the conference will be opened for questions.] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT February 14, 2012 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]
TPI [TIANYIN PHARMACEUTICAL] SC 13G: (Original Filing)
[for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose (Act) or otherwise subject to]
CPHI [CHINA PHARMAS,] SC 13G/A: (Original Filing)
[CUSIP No. 16941T104 1. NAME OF REPORTING PERSONS]
CPHI [CHINA PHARMAS,] SC 13G/A: CUSIP No. 16941T104 1. NAME OF REPORTING PERSONS
[CUSIP No. 16941T104 1. NAME OF REPORTING PERSONS]
SVA [SINOVAC BIOTECH] SC 13G/A: (Original Filing)
[(Name of Issuer) Common Stock (Title of Class of Securities) P8696W104 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. P8696W104 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 3. SEC USE ONLY]
WX [WuXi PharmaTech (Cayman)] SC 13G/A: (Original Filing)
[securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. (Continued on the Following Pages) 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Kylin Fund LP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ]]
WX [WuXi PharmaTech (Cayman)] SC 13G/A: securities, and for any subsequent amendment containing information
[securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. (Continued on the Following Pages) 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Kylin Fund LP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ]]
TPI [TIANYIN PHARMACEUTICAL] SC 13G/A: (Name of Issuer) Common Stock (Title of Class
[(Name of Issuer) Common Stock (Title of Class of Securities) 88630M104 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. 88630M104 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 3. SEC USE ONLY]
